It was also reported that pDCs stimulated with the TLR7 agonist promoted an autoimmune Th17 phenotype and increased levels of type I IFNs were correlated with high amounts of Th17 cytokines in the serum of SLE patients [115,116]. This evidence concerns the gene TLR7 and systemic lupus erythematosus.